Aim: The prevalence and associated factors of dialysis-related sarcopenia could vary greatly according to gender. This study aimed to determine the prevalence of sarcopenia in haemodialysis patients according to gender and to assess some factors related to sarcopenia.
Methods: A cross-sectional study was conducted in maintenance haemodialysis patients. Muscle mass was measured after a dialysis session using bioelectrical impedance analysis. The Asian Working Group for Sarcopenia 2019 definition was applied to diagnose sarcopenia. Logistic regression analysis was applied to determine the associations between several factors and sarcopenia in each gender group.
Results: Among 270 participants (50.7% males, age 52.4 ± 13.8), 47 males (34.3%) and 75 females (56.4%) had sarcopenia. According to multivariate logistic regression, the correlates in males were age (OR 1.035, 95% CI 1.001-1.070, p = 0.044), BMI (OR 0.704, 95% CI 0.582-0.852, p < 0.001), dialysis vintage (OR 1.084, 95% CI 1.019-1.153, p = 0.011) and low income (OR 2.49, 95% CI 1.09-5.65, p = 0.03). In females, age (OR 1.053, 95% CI 1.017-1.091, p = 0.003), BMI (OR 0.746, 95% CI 0.619-0.899, p = 0.002), dialysis vintage (OR 1.109, 95% CI 1.017-1.209, p = 0.019), poor nutritional status (OR 5.17, 95% 2.01-13.28, p = 0.001), and polypharmacy (OR 5.12, 95% CI 1.43-18.42, p = 0.012) were associated with sarcopenia.
Conclusion: Our study showed that sarcopenia was common among haemodialysis patients, and female patients were more susceptible to sarcopenia. There are differences in gender-specific associated factors of sarcopenia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/nep.70018 | DOI Listing |
Background: Interfering RNA therapies (RNAi) have changed the management of patients with hyperoxaluria type 1 (PH1); data in dialysis remain scarce.
Results: A PH1 teenager undergoing intensive hemodiafiltration received lumasiran. POx levels almost halved during the loading phase (98 to 52 µmol/L), but rebound occurred when doses were quarterly-spaced, with POx at 94 µmol/L at 5 months.
Background: The peritoneal dialysis (PD) regimes should be individualized based on clinical tolerance and adequacy. Routine hydrostatic intraperitoneal pressure (IPP) measurements have been suggested to define optimal intraperitoneal dialysate volume (IPV), data on applicability and variability in clinical routine are few.
Methods: We retrospectively analysed 655 IPP measurements monthly performed in 21 children on stable automated PD.
Circ Rep
March 2025
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine Tochigi Japan.
Background: Studies have shown an increased risk of cardiovascular events during treatment with febuxostat vs. allopurinol, but comparative data with another xanthine oxidoreductase inhibitor (XORi), topiroxostat, are lacking. In this retrospective study we compared the incidence of cardiovascular/renal events in Japanese patients with newly diagnosed hyperuricemia and/or gout treated with allopurinol, febuxostat or topiroxostat.
View Article and Find Full Text PDFInt Med Case Rep J
March 2025
Trainee in Plastic Reconstructive and Esthetic Surgery Training Program, Universitas Padjadjaran, Bandung, West Java, Indonesia.
Ischemic steal syndrome (ISS) occurs in hemodialysis patients. Hence, it rarely becomes gangrene or disrupts hand function. We reported a patient with an ISS and radial atherosclerosis that presented with infected ulcer.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!